Literature DB >> 21461319

One more step towards justifying targeted treatment for insomnia.

Michael L Perlis1, Philip Gehrman.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21461319      PMCID: PMC3065251          DOI: 10.1093/sleep/34.4.417

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  7 in total

1.  National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.

Authors: 
Journal:  Sleep       Date:  2005-09       Impact factor: 5.849

2.  The economic impact of insomnia in managed care: a clearer picture emerges.

Authors:  D S Pete Fullerton
Journal:  Am J Manag Care       Date:  2006-05       Impact factor: 2.229

3.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

Authors:  P D Nowell; S Mazumdar; D J Buysse; M A Dew; C F Reynolds; D J Kupfer
Journal:  JAMA       Date:  1997 Dec 24-31       Impact factor: 56.272

4.  The association between insomnia severity and healthcare and productivity costs in a health plan sample.

Authors:  Khaled Sarsour; Anupama Kalsekar; Ralph Swindle; Kathleen Foley; James K Walsh
Journal:  Sleep       Date:  2011-04-01       Impact factor: 5.849

5.  Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy.

Authors:  C M Morin; J P Culbert; S M Schwartz
Journal:  Am J Psychiatry       Date:  1994-08       Impact factor: 18.112

6.  The direct and indirect costs of untreated insomnia in adults in the United States.

Authors:  Ronald J Ozminkowski; Shaohung Wang; James K Walsh
Journal:  Sleep       Date:  2007-03       Impact factor: 5.849

7.  Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.

Authors:  Sonya J Snedecor; Marc F Botteman; Chris Bojke; Kendyl Schaefer; Nadine Barry; A Simon Pickard
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.